<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03587753</url>
  </required_header>
  <id_info>
    <org_study_id>Oxlip-2013 sub amend</org_study_id>
    <nct_id>NCT03587753</nct_id>
  </id_info>
  <brief_title>Experiment 2: Understanding Liver Fat Metabolism</brief_title>
  <acronym>FATOX</acronym>
  <official_title>Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Nutrients on Liver Fat Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a largely unsubstantiated thought in the literature that dietary unsaturated enter
      oxidation pathways preferentially compared to saturated fatty acids. This study is
      undertaking a direct comparison of the oxidation of dietary saturated and unsaturated fatty
      acids.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Provided subjects meet the inclusion criteria, then at least one week after the screening
      visit volunteers will then undertake the first two 'study days'. There will be two study days
      on separate occasions that will be up to 3 weeks apart. Each study day will be approximately
      7 hours in duration. On each study day participants will be given a standardised 'test' meal
      that contains specially labelled fat molecules (stable-isotope tracer) and then repeated
      breath and blood samples will be taken over the course of the next 6 hours. The test meal
      consumed on each 'study day' will be identical in composition with only the specially
      labelled fat molecules being different (either unsaturated or saturated fat) and these will
      be given in a random order.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomised cross-over</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dietary fatty acid partitioning</measure>
    <time_frame>6 hours</time_frame>
    <description>The appearance of the 13Clabelled fatty acid in plasma triglycerides</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Fatty Acid Oxidation</condition>
  <arm_group>
    <arm_group_label>Unsaturated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A test meal containing a unsaturated fatty acid labelled with 13C to measure hepatic fatty acid partitioning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saturated</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A test meal containing a saturated fatty acid labelled with 13C to measure hepatic fatty acid partitioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary fatty acid partitioning</intervention_name>
    <description>There is no intervention as such, just a physiological assessment of the partitioning and oxidation of two different types of dietary fatty acids</description>
    <arm_group_label>Saturated</arm_group_label>
    <arm_group_label>Unsaturated</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Participant is willing and able to give informed consent for participation in the study.

        Male or Female, aged &gt;18 and &lt;65 years BMI &gt;19 &lt;35kg/m2 No medical condition or relevant
        drug therapy known to affect liver metabolism

        Exclusion Criteria:

          -  â€¢ Age &lt;18 or &gt;65 years

               -  Body mass index &lt;19 or &gt;35kg/m2

               -  A blood haemoglobin &lt;120mg/dL

               -  Any metabolic condition or relevant drug therapy

               -  Smoking

               -  History of alcoholism or a greater than recommended alcohol intake

               -  Pregnant or nursing mothers

               -  Women prescribed hormone replacement therapy (HRT) or who have used this within
                  the last 12 months

               -  History of severe claustrophobia

               -  Presence of metallic implants, pacemaker

               -  Haemorrhagic disorders

               -  Anticoagulant treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Oxford Centre for Diabetes, Endocrinology and Metabolism</name>
      <address>
        <city>Oxford</city>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 20, 2018</study_first_submitted>
  <study_first_submitted_qc>July 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2018</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

